Results 111 to 120 of about 2,359,697 (192)

Expert consensus on oral management in autoimmune bullous diseases, erythema multiforme and SJS/TEN. [PDF]

J Eur Acad Dermatol Venereol
Nayee S, Harte M, Ingen-Housz-Oro S, Ameri M, Walsh S, Joly P, Ardern-Jones M, Brailo V, Brueggen MC, Bunker C, Carey B, Carrozzo M, Chua SL, Creamer D, Culton D, Delli K, Diniz-Freitas M, Dodiuk-Gad R, Dridi SM, Ejeil AL, French L, Gaspar K, Higham J, Horvarth B, Hullah E, Jurge S, McMillan R, McParland H, Murrell D, Ormond M, Poveda-Gallego A, Samimi M, Schmidt E, Shephard M, Sollecito T, Taylor J, Uzun S, Valiukeviciene S, Willis A, Setterfield J.   +39 more
europepmc   +1 more source

Preface to The Journal of Dermatology special issue: What's new in autoimmune bullous diseases. [PDF]

J Dermatol, 2023
Tsuruta D.
europepmc   +1 more source

Factors associated with prolonged hospital stay in patients with autoimmune bullous diseases treated at an in-patient dermatology service. [PDF]

Skin Health Dis
Saldarriaga-Muñoz PJ, Rodelo-Sánchez V, Agudelo-Aguilar I, Osorio-Álvarez D, Valencia-Montoya S, Bedoya-Mejía S, Chiquito-García S, Ayala-Monroy GA.   +7 more
europepmc   +1 more source

Systemic Implications of Bullous Pemphigoid: Bridging Dermatology and Internal Medicine

Background: Bullous pemphigoid is an autoimmune bullous disease that frequently affects a large skin surface area, but it can also present in localized areas.
Natsuko Saito-Sasaki, Yu Sawada, Emi Mashima   +2 more
core   +1 more source

Hemidesmosome Mutations Contribute to the Onset and Severity of Acquired Autoimmune Bullous Diseases. [PDF]

MedComm (2020)
Cao S, Wang T, Lv C, Ma S, Yu G, Xia Q, Liu T, Yu Y, Sun L, Pei X, Zhao Q, Wang Z, Wang C, Liu Y, Chen S, Wang J, Zhou G, Liu H, Sun Y, Zhang F.   +19 more
europepmc   +1 more source

Adverse outcome and severity of COVID-19 in patients with autoimmune bullous diseases: A historical cohort study. [PDF]

Dermatol Ther, 2022
Moghadam FS, Kianfar N, Dasdar S, Samii R, Farimani Z, Azar PM, Balighi K, Abedini R, Soori T, Farid AS, Mahmoudi H, Daneshpazhooh M.   +11 more
europepmc   +1 more source

Autoimmune bullous diseases: pathogenesis and clinical management. [PDF]

Mol Biomed
Feng X, Zheng H, Wang M, Wang Y, Zhou X, Zhang X, Li J, Xiao Y, Wei M, Li X, Hashimoto T, Li J, Li W.   +12 more
europepmc   +1 more source

Investigation of comorbid autoimmune diseases in women with autoimmune bullous diseases: An interplay of autoimmunity and practical implications. [PDF]

Int J Womens Dermatol, 2022
Karakioulaki M, Murrell DF, Kyriakou A, Patsatsi A.   +3 more
europepmc   +1 more source

Sita- and saxagliptin use and autoantibodies to autoimmune bullous diseases: A cross-sectional study. [PDF]

J Eur Acad Dermatol Venereol
Dräger S, Kauderer C, Meyhöfer S, Dräger L, Marquardt JU, Ludwig RJ, Arndt S, Boch K, Bieber K.   +8 more
europepmc   +1 more source

Association between COVID-19 vaccination and autoimmune bullous diseases: a random coincidence or rare event. [PDF]

J Eur Acad Dermatol Venereol, 2022
Kasperkiewicz M.
europepmc   +1 more source